ArticleFrontiers in public health2025
A science-based product regulation: the time has come to reduce toxic emissions to reduce harm.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Commentary: A science-based product regulation: the time has come to reduce toxic emissions to reduce harm.Frontiers in public health · 2025Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tobacco control has focused on reducing use, with little emphasis on regulating product toxicity. Articles 9 and 10 of the World Health Organization's Framework Convention on Tobacco Control (FCTC) offer a mechanism to reduce harm by limiting toxic emissions, but implementation has stalled. A science-based regulatory framework is needed to set emission thresholds for toxicants. Inspiration can be found from other regulated sectors, and the initial focus should be on nine priority toxicants strongly linked to tobacco-related disease. An adaptive, evidence-based approach can complement existing strategies and accelerate harm reduction for more than 1 billion people who still smoke. The 11th FCTC Conference of the Parties in 2025 presents an opportunity to revisit the development of a toxicity reduction strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.